Reynolds, R D <br/><br/>
Phase I clinical trial of MAF containing preparation of RPMI-1788 B-cell human lymphoblastoid lymphokine in advanced cancer patients.  [electronic resource] 

 -  Lymphokine research  1986 
 - S165-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0277-6766 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B-Lymphocytes--immunology<br/>Drug Evaluation<br/>Female<br/>Fever--chemically induced<br/>Humans<br/>Immunotherapy<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Lymphokines--administration & dosage<br/>Macrophage-Activating Factors<br/>Male<br/>Neoplasms--immunology